Hot Features
Registrieren Sie sich für Echtzeit-Benachrichtigungen, benutzerdefinierte Portfolios und Marktbewegungen.
TORONTO, April 28, 2021 (GLOBE NEWSWIRE) -- Anaconda Mining Inc. ("Anaconda" or the "Company") (TSX: ANX) (OTCQX: ANXGF) is pleased to announce that it has entered into an agreement with Raymond...
THIS NEWS RELEASE IS NOT FOR DISTRIBUTION IN THE UNITED STATES OR TO U.S. NEWS AGENCIES VANCOUVER, British Columbia, March 21, 2019 (GLOBE NEWSWIRE) -- Asante Gold Corporation (CSE:ASE/...
PHOENIX, Aug. 13, 2018 (GLOBE NEWSWIRE) -- Anaconda Mining Inc. (TSX:ANX) (OTCQX:ANXGF) (“Anaconda” or the “Company”) announced President, CEO and Director, Dustin Angelo’s interview on Uptick...
OTC Markets Group Welcomes Anaconda Mining Inc. to OTCQX PR Newswire NEW YORK, May 9, 2018 NEW YORK, May 9, 2018 /PRNewswire/ -- OTC Markets Group Inc. (OTCQX: OTCM), operator of financial...
SAN DIEGO, Feb. 4 /PRNewswire-FirstCall/ -- ADVENTRX Pharmaceuticals, Inc. (NYSE Amex: ANX) today announced that, effective immediately, Brian M. Culley, previously the Company's Chief Business...
SAN DIEGO, Feb. 3 /PRNewswire-FirstCall/ -- ADVENTRX Pharmaceuticals, Inc. (NYSE Amex: ANX) today announced that Odysseas D. Kostas, M.D. will join its Board of Directors. Dr. Kostas also will...
SAN DIEGO, Feb. 2 /PRNewswire-FirstCall/ -- ADVENTRX Pharmaceuticals, Inc. (NYSE Amex: ANX) today announced that the Company's Principal Executive Officer, Brian M. Culley, will present at the...
SAN DIEGO, Jan. 7 /PRNewswire-FirstCall/ -- ADVENTRX Pharmaceuticals, Inc. (NYSE Amex: ANX) announced today that it has completed the previously announced sale of shares of its Series E...
SAN DIEGO, Jan. 6 /PRNewswire-FirstCall/ -- ADVENTRX Pharmaceuticals, Inc. (NYSE Amex: ANX) today announced that the Company's Principal Executive Officer, Brian M. Culley, will present at the...
SAN DIEGO, Jan. 4 /PRNewswire-FirstCall/ -- ADVENTRX Pharmaceuticals, Inc. (NYSE Amex: ANX) announced today that it has signed agreements to purchase shares of its Series E convertible preferred...
| Zeitraum † | Änderung | Änderung % | Handelsbeginn | Hoch | Niedrig | Durchsch. Volumen | VWAP | |
|---|---|---|---|---|---|---|---|---|
| 1 | 0 | 0 | 0.51 | 0.51 | 0.51 | 0 | 0 | CS |
| 4 | 0 | 0 | 0.51 | 0.51 | 0.51 | 0 | 0 | CS |
| 12 | 0 | 0 | 0.51 | 0.51 | 0.51 | 0 | 0 | CS |
| 26 | 0 | 0 | 0.51 | 0.51 | 0.51 | 0 | 0 | CS |
| 52 | 0 | 0 | 0.51 | 0.51 | 0.51 | 0 | 0 | CS |
| 156 | -0.14 | -21.5384615385 | 0.65 | 0.94 | 0.46 | 11980 | 0.73538312 | CS |
| 260 | 0.305 | 148.780487805 | 0.205 | 1.05 | 0.095 | 87125 | 0.56606298 | CS |
Die zuletzt besuchten Aktien werden in diesem Feld angezeigt, so dass Sie leicht zu den Aktien zurückkehren können, die Sie zuvor angesehen haben.
Support: +44 (0) 203 8794 460 | support@advfn.de
Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen
Premium
4
